Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Natural history of untreated primary hepatocellular carcinoma: a retrospective study of 157 patients.

Pawarode A, Voravud N, Sriuranpong V, Kullavanijaya P, Patt YZ.

Am J Clin Oncol. 1998 Aug;21(4):386-91.

PMID:
9708639
2.

Outcomes of primary hepatocellular carcinoma treatment: an 8-year experience with 368 patients in Thailand.

Pawarode A, Tangkijvanich P, Voravud N.

J Gastroenterol Hepatol. 2000 Aug;15(8):860-4.

PMID:
11022825
3.

Natural history of untreated nonsurgical hepatocellular carcinoma.

Yeung YP, Lo CM, Liu CL, Wong BC, Fan ST, Wong J.

Am J Gastroenterol. 2005 Sep;100(9):1995-2004.

PMID:
16128944
4.

Evaluation of predictive value of CLIP, Okuda, TNM and JIS staging systems for hepatocellular carcinoma patients undergoing surgery.

Huang YH, Chen CH, Chang TT, Chen SC, Wang SY, Lee HS, Lin PW, Huang GT, Sheu JC, Tsai HM, Lee PC, Chau GY, Lui WY, Lee SD, Wu JC.

J Gastroenterol Hepatol. 2005 May;20(5):765-71.

PMID:
15853992
5.
6.

Treatment and prognostic factors in patients with hepatocellular carcinoma.

Martins A, Cortez-Pinto H, Marques-Vidal P, Mendes N, Silva S, Fatela N, Glória H, Marinho R, Távora I, Ramalho F, de Moura MC.

Liver Int. 2006 Aug;26(6):680-7.

PMID:
16842324
7.

Is liver resection justified in advanced hepatocellular carcinoma? Results of an observational study in 464 patients.

Ruzzenente A, Capra F, Pachera S, Iacono C, Piccirillo G, Lunardi M, Pistoso S, Valdegamberi A, D'Onofrio M, Guglielmi A.

J Gastrointest Surg. 2009 Jul;13(7):1313-20. doi: 10.1007/s11605-009-0903-x. Epub 2009 May 6.

PMID:
19418103
8.

Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib: a retrospective comparison with previously known prognostic models.

Baek KK, Kim JH, Uhm JE, Park SH, Lee J, Park JO, Park YS, Kang WK, Lim HY.

Oncology. 2011;80(3-4):167-74. doi: 10.1159/000327591. Epub 2011 Jun 24.

PMID:
21701230
9.

Prognostic value and clinical relevance of the 6th Edition 2002 American Joint Committee on Cancer staging system in patients with resectable hepatocellular carcinoma.

Lei HJ, Chau GY, Lui WY, Tsay SH, King KL, Loong CC, Wu CW.

J Am Coll Surg. 2006 Oct;203(4):426-35. Epub 2006 Aug 23.

PMID:
17000385
10.

[Hepatocellular carcinoma in the elderly: clinical characteristics, survival analysis, and prognostic indicators in a cohort of Spanish patients older than 75 years].

Fernández-Ruiz M, Guerra-Vales JM, Llenas-García J, Colina-Ruizdelgado F.

Rev Esp Enferm Dig. 2008 Oct;100(10):625-31. Spanish.

PMID:
19119788
12.

Long-term outcomes and prognostic factors of elderly patients with hepatocellular carcinoma undergoing hepatectomy.

Huang J, Li BK, Chen GH, Li JQ, Zhang YQ, Li GH, Yuan YF.

J Gastrointest Surg. 2009 Sep;13(9):1627-35. doi: 10.1007/s11605-009-0933-4. Epub 2009 Jun 9.

PMID:
19506976
13.

Multimodality treatment for patients with hepatocellular carcinoma: analysis of prognostic factors in a single Western institution series.

Medina-Franco H, Sellers MT, Eckhoff DE, Bynon JS, Urist MM, Heslin MJ.

J Gastrointest Surg. 2001 Nov-Dec;5(6):638-45.

PMID:
12086903
14.
15.

[Survival analysis for patients with hepatocellular carcinoma according to stage, liver function and treatment modalities].

Park KW, Park JW, Cho SH, Kim YI, Kim SH, Park HS, Lee WJ, Park SJ, Kim DY, Hong EK, Kim CM.

Korean J Hepatol. 2006 Mar;12(1):41-54. Korean.

16.

Brain metastases from hepatocellular carcinoma: prognostic factors and outcome: brain metastasis from HCC.

Choi HJ, Cho BC, Sohn JH, Shin SJ, Kim SH, Kim JH, Yoo NC.

J Neurooncol. 2009 Feb;91(3):307-13. doi: 10.1007/s11060-008-9713-3. Epub 2008 Oct 23.

PMID:
18949445
17.

Prognostic factors after hepatic resection for hepatocellular carcinoma with hepatitis C viral infection: univariate and multivariate analysis.

Hanazaki K, Kajikawa S, Koide N, Adachi W, Amano J.

Am J Gastroenterol. 2001 Apr;96(4):1243-50.

PMID:
11316177
18.

Do young hepatocellular carcinoma patients have worse prognosis? The paradox of age as a prognostic factor in the survival of hepatocellular carcinoma patients.

Chen CH, Chang TT, Cheng KS, Su WW, Yang SS, Lin HH, Wu SS, Lee CM, Changchien CS, Chen CJ, Sheu JC, Chen DS, Lu SN.

Liver Int. 2006 Sep;26(7):766-73.

PMID:
16911457
19.

Do young hepatocellular carcinoma patients with relatively good liver function have poorer outcomes than elderly patients?

Cho SJ, Yoon JH, Hwang SS, Lee HS.

J Gastroenterol Hepatol. 2007 Aug;22(8):1226-31. Epub 2007 May 13.

PMID:
17498220
20.

Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study.

Kim HS, Park JW, Jang JS, Kim HJ, Shin WG, Kim KH, Lee JH, Kim HY, Jang MK.

J Clin Gastroenterol. 2009 May-Jun;43(5):482-8. doi: 10.1097/MCG.0b013e318182015a.

PMID:
19197197

Supplemental Content

Support Center